RE:Why low-cost ketamine is still inaccessible to many... The article describes very well that ketamine can help in many areas of medicine, but that this fails due to regulations, among other things.
If the FDA grants approval, which I assume it will, a gigantic market will open up for Pharmather.
I don't want to speculate on share prices, but Pharmather would be the only company with official approval, which could send the share price into the stratosphere.
Best luck to all holders!
J.B.